Financials
- Market Capitalization 2.62 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1777 | ATAI AtaiBeckley Inc. - Common Stock | 7.35 USD | +0.14% | -1.08% | +2.37% | +86.08% | 2.73 B USD | ||
| 1797 | NRIX Nurix Therapeutics, Inc. - Common stock | 25.91 USD | +0.50% | -4.18% | +12.85% | +131.13% | 2.69 B USD | ||
| 1811 | VRDN Viridian Therapeutics, Inc. - Common Stock | 23.14 USD | -0.09% | -5.70% | +23.09% | +3.07% | 2.62 B USD | ||
| 1833 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.74 USD | +2.10% | -4.17% | +3.29% | -15.61% | 2.54 B USD |